Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,081 | -10,532 | -30,359 | -15,492 | -4,892 |
| Depreciation Amortization | 1 | 419 | 91 | 73 | 54 |
| Accounts receivable | -391 | -605 | -227 | -455 | -518 |
| Other Working Capital | -11 | -223 | 417 | -19 | -725 |
| Other Operating Activity | -4,026 | 6,986 | 27,739 | 14,036 | 4,999 |
| Operating Cash Flow | $-346 | $-3,955 | $-2,339 | $-1,857 | $-1,082 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -13 | -15 | -15 | -13 |
| Investing Cash Flow | $N/A | $-13 | $-15 | $-15 | $-13 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -2,750 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 4,654 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $1,904 | $N/A | $0 | $N/A |
| Beginning Cash Position | 396 | 2,460 | 2,460 | 2,460 | 2,460 |
| End Cash Position | 50 | 396 | 106 | 588 | 1,365 |
| Net Cash Flow | $-346 | $-2,064 | $-2,354 | $-1,872 | $-1,095 |
| Free Cash Flow | |||||
| Operating Cash Flow | -346 | -3,955 | -2,339 | -1,857 | -1,082 |
| Capital Expenditure | N/A | -13 | -15 | -15 | -13 |
| Free Cash Flow | -346 | -3,968 | -2,354 | -1,872 | -1,095 |